Cargando…

Vitamin D, bone alkaline phosphatase and parathyroid hormone in healthy subjects and haemodialysed patients from West Africa: impact of reference ranges and parathyroid hormone generation assays on the KDIGO guidelines

BACKGROUND: The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend targets based on multiples of the upper limit of normal (ULN) of parathyroid hormone (PTH) concentration. However, the ULN has not always been correctly established by manufacturers. While it is known that the ULN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cavalier, Etienne, Sagou Yayo, Eric, Attoungbre-Hauhouot, Marie-Laure, Konan, Jean-Louis, Yao-Yapo, Carine, Monnet, Dagui, Gnionsahé, Appolinaire, Souberbielle, Jean-Claude, Delanaye, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	CKD-Mbd
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452202/ https://www.ncbi.nlm.nih.gov/pubmed/30976410 http://dx.doi.org/10.1093/ckj/sfy074

Ejemplares similares

Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease
por: Ureña-Torres, Pablo A, et al.
Publicado: (2018)

Disrupted tubular parathyroid hormone/parathyroid hormone receptor signaling and damaged tubular cell viability possibly trigger postsurgical kidney injury in patients with advanced hyperparathyroidism
por: Sato, Tetsuhiko, et al.
Publicado: (2019)

Factors associated with parathyroid hormone control in haemodialysis patients with secondary hyperparathyroidism treated with cinacalcet in real-world clinical practice: Mimosa study
por: Rottembourg, Jacques, et al.
Publicado: (2019)

Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients
por: Fouque, Denis, et al.
Publicado: (2018)

Soluble klotho may be a marker of phosphate reabsorption
por: Tan, Sven-Jean, et al.
Publicado: (2017)

Multimodal treatment of calcific uraemic arteriolopathy (calciphylaxis): a case series
por: Russo, Domenico, et al.
Publicado: (2016)

Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients
por: Cianciolo, Giuseppe, et al.
Publicado: (2016)

The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials
por: Caluwé, Rogier, et al.
Publicado: (2016)

Is progression of coronary artery calcification influenced by modality of renal replacement therapy? A systematic review
por: Jansz, Thijs T, et al.
Publicado: (2018)

Calciphylaxis in a dialysis patient successfully treated with high-dose vitamin K supplementation
por: Christiadi, Daniel, et al.
Publicado: (2018)

Multi-intervention management of calcific uremic arteriolopathy in 24 patients
por: Harris, Claire, et al.
Publicado: (2018)

Is chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype?
por: Cianciolo, Giuseppe, et al.
Publicado: (2017)

Gastrointestinal complications induced by sevelamer crystals
por: Yuste, Claudia, et al.
Publicado: (2017)

Placebo-controlled, randomized clinical trial of high-dose cholecalciferol in renal dialysis patients: effect on muscle strength and quality of life
por: Singer, Richard, et al.
Publicado: (2018)

Are oxyphil cells responsible for the ineffectiveness of cinacalcet hydrochloride in haemodialysis patients?
por: Rottembourg, Jacques, et al.
Publicado: (2018)

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3
por: Bouma-de Krijger, Annet, et al.
Publicado: (2019)

Small steps towards the potential of ‘preventive’ treatment of early phosphate loading in chronic kidney disease patients
por: Bover, Jordi, et al.
Publicado: (2019)

CKD-MBD KDIGO guidelines: how difficult is reaching the ‘target’?
por: Cozzolino, Mario
Publicado: (2018)

Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients
por: Delanaye, Pierre, et al.
Publicado: (2017)

Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation
por: Kimura, Shigemi, et al.
Publicado: (2014)

Analysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients
por: Jean, Guillaume, et al.
Publicado: (2016)

The Parathyroid Hormone-Related Protein/Parathyroid Hormone 1 Receptor Axis in Adipose Tissue
por: Izquierdo-Lahuerta, Adriana
Publicado: (2021)

Parathyroid Hormone-Related Protein/Parathyroid Hormone Receptor 1 Signaling in Cancer and Metastasis
por: Zhao, Yawei, et al.
Publicado: (2023)

Inhibition of Parathyroid Hormone Secretion by Caffeine in Human Parathyroid Cells
por: Lu, Ming, et al.
Publicado: (2013)

Parathyroid hormone and vitamin D.
por: Harrison, H. E.
Publicado: (1966)

Parathyroid Hormone Signaling in Osteocytes
por: Wein, Marc N
Publicado: (2017)

Parathyroid hormone 1-34 and skeletal anabolic action: The use of parathyroid hormone in bone formation
por: Osagie-Clouard, L., et al.
Publicado: (2017)

Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder
por: Turan, Serap
Publicado: (2017)

IMMUNOCHEMICAL IDENTIFICATION OF PARATHYROID HORMONE IN NON-PARATHYROID NEOPLASMS ASSOCIATED WITH HYPERCALCEMIA
por: Tashjian, Armen H., et al.
Publicado: (1964)

Parathyroid carcinoma survival: improvements in the era of intact parathyroid hormone monitoring?
por: Allen, Miya E., et al.
Publicado: (2013)

Atypical parathyroid tumor: clinical and parathyroid hormone response to surgical treatment
por: Napolitano, Antonio Giulio, et al.
Publicado: (2023)

The value of intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism and varying baseline parathyroid hormone levels
por: Hargitai, Lindsay, et al.
Publicado: (2022)

Effects of Parathyroid Hormone on Immune Function
por: Geara, Abdallah Sassine, et al.
Publicado: (2010)

Annotation: Parathyroid hormone and fracture healing
por: Aspenberg, Per
Publicado: (2013)

Hypoparathyroidism: Replacement Therapy with Parathyroid Hormone
por: Rejnmark, Lars, et al.
Publicado: (2015)

Therapy of Hypoparathyroidism by Replacement with Parathyroid Hormone
por: Rejnmark, Lars, et al.
Publicado: (2014)

Therapy of aseptic nonunions with parathyroid hormone
por: Kastirr, I., et al.
Publicado: (2018)

Radioimmunoassay of Parathyroid Hormone in Primary Hyperparathyroidism
por: Buckle, R. M.
Publicado: (1968)

Parathyroid hormone is associated with prostate cancer
por: Kim, Won Tae, et al.
Publicado: (2020)

Parathyroid hormone assay: problems and opportunities
por: Martin, Kevin J., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_njgnbuchk16ngnaqnvgifqdgrv